Clover Health Investments (CLOV) Change in Account Payables (2020 - 2026)

Clover Health Investments has reported Change in Account Payables for 7 years, with the latest figure at -$65.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Account Payables fell 50.3% year-over-year to -$65.3 million; the trailing twelve-month figure through Mar 2026 stood at -$44.5 million (down 215.07% YoY), and the FY2025 full-year result was -$22.6 million, down 17.96% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$65.3 million, down from -$18.3 million in the prior quarter.
• The five-year high for Change in Account Payables was $109.2 million in Q3 2022, with the low at -$94.8 million in Q4 2022.
• Historically, Change in Account Payables has averaged -$5.5 million across 5 years, with a median of -$13.6 million in 2023.
• Annual changes were most pronounced in 2022 — Change in Account Payables slumped 1702.3% — and 2024, when it jumped 342.43%.
• Clover Health Investments' Change in Account Payables stood at -$94.8 million in 2022, then surged by 93.22% to -$6.4 million in 2023, then plunged by 215.55% to -$20.3 million in 2024, then gained by 9.78% to -$18.3 million in 2025, then sank by 256.95% to -$65.3 million in 2026.
• The last three Change in Account Payables figures came in at -$65.3 million (Q1 2026), -$18.3 million (Q4 2025), and $38.9 million (Q3 2025), per Business Quant data.